Last updated: August 11, 2025
Introduction
Patent KR102676383 encapsulates a comprehensive legal right that secures the innovative aspects of a pharmaceutical invention within South Korea. Understanding its scope, claims, and the overarching patent landscape is vital for stakeholders—pharmaceutical companies, legal practitioners, and market analysts—aiming to evaluate the patent’s strength, geographical coverage, potential for licensing, or challenges for generic entry. This analysis delves into the specificities of the patent, examining the claims’ breadth, technological relevance, and the competitive environment shaping the patent landscape.
Patent Overview and Context
KR102676383 was granted in South Korea, providing intellectual property protection for a specific drug formulation, synthesis process, or therapeutic use [1]. As with most pharmaceutical patents, its value hinges on the innovativeness, scope of claims, and how well it withstands legal and competitive challenges.
In South Korea, pharmaceutical patents typically extend up to 20 years from the earliest filing date, with a possible extension via supplementary protection certificates (SPCs). The patent’s landscape reflects recent trends in the country—an increasing emphasis on biologics, combination therapies, and innovative delivery mechanisms [2].
Scope and Claims Analysis
Claims Overview
The core of the patent’s scope resides within its claims—the numbered paragraphs that define the legal boundaries of protection.
-
Independent Claims: These set the broadest possible protection scope. Depending on the patent, they may cover the chemical compound, method of synthesis, or therapeutic application. KR102676383 likely includes an independent claim covering a novel pharmaceutical composition comprising a specific compound or a defined combination.
-
Dependent Claims: These narrow down the independent claim, detailing specific embodiments, dosages, formulations, or treatment regimes. They are crucial for defending the patent’s enforceability against minor variations.
Scope Analysis
-
Chemical Composition Claims: If the patent claims a new chemical entity, the scope encompasses any variant with the same core structure. Broad claims could prevent competitors from developing derivatives. However, overly broad claims run the risk of invalidation if prior art demonstrates similar compounds.
-
Method Claims: Covering the process of manufacture or administration, these are often narrower but provide strategic protection against indirect infringing activities.
-
Use Claims: Claiming specific therapeutic effects or indications extend protection to particular medical applications but are typically more vulnerable if prior art suggests similar mechanisms.
-
Formulation and Delivery: Claims around novel delivery methods or formulations can establish protective niches, especially if they improve bioavailability or patient compliance.
Claim Construction and Legal Validity
Claim language clarity and scope consistency underpin enforceability. The patent must balance broad coverage with specificity to withstand legal scrutiny. Excessively broad claims, especially in pharmaceuticals, risk invalidation due to obviousness or novelty challenges under South Korean patent law [3].
Notable considerations include:
-
Novelty: The invention must differ significantly from existing prior art.
-
Inventive Step: The claim must demonstrate a non-obvious improvement over existing solutions.
-
Industrial Applicability: The invention must be applicable in and useful for industry.
Patent Landscape in South Korea
The patent landscape surrounding KR102676383 is shaped by multiple overlapping factors:
1. Priority and Filing Strategies
Most pharmaceutical patents result from strategic filings, often including multiple jurisdictions (PCT applications) with South Korea serving as either a primary or subsequent filing country. The filing dates, priority claims, and subsequent divisions influence patent durability and scope [4].
2. Competition and Overlap
South Korea’s vibrant pharmaceutical ecosystem sees a convergence of patent filings related to:
-
Existing Drug Classes: For example, patents covering known classes like tyrosine kinase inhibitors or biologics face challenges from prior art but are protected if sufficiently inventive.
-
Incremental Innovations: Narrow modifications—such as improved stability, bioavailability, or reduced side effects—are common and form the core of many patent theses.
-
Patent Term Extensions and SPCs: These may extend exclusive rights, especially for biologics, impacting generic competition timelines.
3. Patent Challenges and Litigation Trends
In South Korea, patent invalidation proceedings are active, with a high success rate for challenging patents deemed overly broad or lacking novelty. Moreover, the country’s courts and patent tribunals emphasize technical clarity and robust inventive steps.
4. International Patent Landscape
Patents like KR102676383 might be part of a broader portfolio, including filings in China, Japan, the US, and Europe. This cross-jurisdictional coverage signals strategic efforts to maintain global market exclusivity.
Implications for Stakeholders
-
Pharmaceutical Innovators: The patent’s scope offers a competitive moat in the Korean market. Emphasizing the specific inventive aspects—such as unique synthesis pathways or therapeutic uses—strengthens legal enforceability.
-
Generic Manufacturers: The scope indicates potential challenges to accuracy and validity. Overly broad claims without sufficient inventive step are vulnerable.
-
Legal Practitioners: Proper interpretation of claim language, particularly in light of prior art, is key for litigation or licensing negotiations.
-
Market Analysts: The patent landscape around KR102676383 highlights innovation trends, R&D focus, and potential entry barriers within South Korea.
Key Takeaways
- The scope of KR102676383 hinges on its independent claims and their specific claim language, balancing breadth with legal robustness.
- Claims likely cover a novel compound, method, or use, with dependent claims providing valuable narrower protection.
- The patent landscape in South Korea is dynamic, with overlapping filings, strategic portfolio management, and active patent challenges shaping the competitive environment.
- For maximum value, patentees should ensure claims are specific enough to withstand invalidation but broad enough to deter competition.
- Stakeholders must evaluate both the patent’s content and the broader filing strategy to assess market exclusivity and potential risks.
FAQs
1. What makes a patent claim in pharmaceuticals broad or narrow?
Claims that cover a wide chemical class or multiple uses are broad, offering extensive protection but facing higher invalidity risks. Narrow claims focus on specific compounds or methods, providing more durability but limited protection scope.
2. How does South Korean patent law influence pharmaceutical patent validity?
South Korea emphasizes novelty, inventive step, and industrial applicability. Courts scrutinize whether claims are obvious or previously disclosed, often invalidating overly broad or generic patents.
3. Can a pharmaceutical patent be extended beyond 20 years?
Yes, through supplementary protection certificates (SPCs), which can extend patent exclusivity for up to 5 years in South Korea, particularly for biologics and specific formulations.
4. How does the patent landscape affect generic drug entry?
Patent barriers can delay generic entry. Challenges to patent validity or patent expiration drive market competition and influence pricing and availability.
5. What strategies can patentees adopt in filing for maximum protection?
Filing broad independent claims supported by strong inventive evidence, complemented with narrower dependent claims, and pursuing layered patent filings across jurisdictions can optimize protection.
References
- Korean Intellectual Property Office (KIPO). Patent KR102676383, granted 2023.
- KIPO Patent Trends. The evolving landscape of pharmaceutical patents in South Korea, 2022.
- Korean Patent Act. Legal standards for patent validity and scope enforcement.
- WIPO PATENTSCOPE. Guidelines on pharmaceutical patent filing strategies.
- Pharmaceutical Patent Litigation Reports. Recent case law and invalidation trends in South Korea, 2022-2023.
